FDA approves generic version of Novo Nordisk's GLP-1 diabetes drug Victoza

Get the Full StoryThe Food and Drug Administration on Monday approved Hikma Pharmaceuticals generic version of Novo Nordisk s diabetes drug Victoza, which is currently in shortage in the country.

Share: